GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torii Pharmaceutical Co Ltd (TSE:4551) » Definitions » 5-Year Yield-on-Cost %

Torii Pharmaceutical Co (TSE:4551) 5-Year Yield-on-Cost % : 7.99 (As of May. 15, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Torii Pharmaceutical Co 5-Year Yield-on-Cost %?

Torii Pharmaceutical Co's yield on cost for the quarter that ended in Mar. 2024 was 7.99.


The historical rank and industry rank for Torii Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:

TSE:4551' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.58   Med: 4.4   Max: 9.68
Current: 7.99


During the past 13 years, Torii Pharmaceutical Co's highest Yield on Cost was 9.68. The lowest was 1.58. And the median was 4.40.


TSE:4551's 5-Year Yield-on-Cost % is ranked better than
89.04% of 502 companies
in the Drug Manufacturers industry
Industry Median: 2.095 vs TSE:4551: 7.99

Competitive Comparison of Torii Pharmaceutical Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Torii Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Torii Pharmaceutical Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torii Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Torii Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.



Torii Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Torii Pharmaceutical Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Torii Pharmaceutical Co  (TSE:4551) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Torii Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Torii Pharmaceutical Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Torii Pharmaceutical Co (TSE:4551) Business Description

Traded in Other Exchanges
N/A
Address
Torii Nihonbashi Buildingg, 4-1, Nihonbashi-Honcho, 3-chome, Chuo-ku, Tokyo, JPN, 103-8439
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.

Torii Pharmaceutical Co (TSE:4551) Headlines

No Headlines